Markets Try To Recover; Regeneron, Clorox And Campbell Soup Hit New Highs

TL;DR

Regeneron shows strength in combating the virus, while Clorox and Campbell's see sales boosts from consumer hoarding. However, volatility and uncertainty persist in these stocks.

Transcript

good afternoon everyone and welcome to stock market today it's alyssa chorim and justin nielsen here and on today's show we're gonna be taking a look at Regeneron as well as Clorox and Campbell's but before but before we get to that let's take a look at the major indexes here you can see the chart of the Nasdaq we saw across-the-board gains of 6% o... Read More

Key Insights

• 🛀 The Nasdaq composite has shown gains of 6% or more, but it is too early to determine if this indicates a market bottom.
• 🧘 Regeneron's experience in combating viruses, such as Ebola, positions it as a potentially impactful player in finding a solution to the current virus illnesses.
• 🤨 Clorox and Campbell's have seen sales boosts due to consumer hoarding, but their weak track record for earnings and sales growth raises concerns about their long-term performance.
• ❓ Volatility and uncertainty persist in the stock market, and caution is advised when considering investments in companies affected by the pandemic.
• 🥺 The market is still trying to price out the impact of the pandemic, leading to additional volatility in stocks.
• 🍗 Investors should be patient and avoid trying to pick the bottom of the market during this time.
• 🥳 The IBD Live program offers trusted information and analysis for identifying proper follow-through days and making appropriate investment decisions.

Questions & Answers

Q: What is the current market trend for the Nasdaq composite?

The Nasdaq composite has shown gains of 6% or more, but it is still too early to determine if this indicates the bottom of the market. The recent rally is not enough to surpass the historic losses from the previous day.

Q: Why is Regeneron gaining attention during the pandemic?

Regeneron has gained about 11.5% as investors hope that the company can offer a solution to the current virus illnesses. The company has experience in combating viruses, such as Ebola, and has developed antibodies that can potentially be used as a treatment.

Q: How are Clorox and Campbell's affected by the pandemic?

Clorox and Campbell's have seen volatility in their stocks due to consumer hoarding of supplies. While they have experienced sales boosts, their track record for earnings and sales growth is weak.

Q: Should investors consider buying stocks in these companies?

It is advisable to exercise caution when considering stocks in these companies due to their current volatility and uncertain market conditions. The impact of the pandemic on their sales and earnings is still uncertain.

Summary & Key Takeaways

• The Nasdaq composite has seen gains of 6% or more, but it is too early to determine if this is the bottom of the market.

• Regeneron has gained 11.5% as investors hope for a solution to the virus. The company has experience in combating viruses, such as Ebola.

• Clorox and Campbell's have seen volatility and sales boosts due to consumer hoarding, but their track record for earnings and sales growth is weak.